Vaxart (NASDAQ: VXRT) reported Q3 EPS of ($0.11), $0.07 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Vaxart (VXRT) click here.